Alternative p38 MAPKs Are Essential for Collagen‐Induced Arthritis
Objective The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38γ and p38δ deficiency in the collagen‐induced arthritis (CIA) model. Methods Wild‐type, p38γ−/−, p38δ−/−, and p38γ/δ−/− mice were immunized with chicken type II collagen, and...
Saved in:
Published in | Arthritis & rheumatology (Hoboken, N.J.) Vol. 66; no. 5; pp. 1208 - 1217 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.05.2014
|
Subjects | |
Online Access | Get full text |
ISSN | 2326-5191 2326-5205 2326-5205 |
DOI | 10.1002/art.38327 |
Cover
Abstract | Objective
The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38γ and p38δ deficiency in the collagen‐induced arthritis (CIA) model.
Methods
Wild‐type, p38γ−/−, p38δ−/−, and p38γ/δ−/− mice were immunized with chicken type II collagen, and disease activity was evaluated by semiquantitative scoring and histologic assessment. Serum cytokine levels and in vitro T cell cytokine responses were quantified by flow cytometry and multiplex analysis, and serum anticollagen antibody levels by enzyme‐linked immunosorbent assay. Cytokine and p38 MAPK isoform expression in joints were determined by quantitative polymerase chain reaction.
Results
Compound p38γ and p38δ deficiency markedly reduced arthritis severity compared with that in wild‐type mice, whereas lack of either p38γ or p38δ had an intermediate effect. Joint damage was minimal in arthritic p38γ/δ−/− mice compared with wild‐type mice. The p38γ/δ−/− mice had lower levels of pathogenic anticollagen antibodies and interleukin‐1β (IL‐1β) and tumor necrosis factor α than controls. In vitro T cell assays showed reduced proliferation, interferon‐γ (IFNγ) production, and IL‐17 production by lymph node cells from p38γ/δ−/− mice. IL‐17 and IFNγ messenger RNA expression in joints was significantly inhibited in p38γ/δ−/− mice. Wild‐type chimeric mice with p38γ/δ−/− bone marrow did not show decreased CIA.
Conclusion
Reduced disease severity in p38γ/δ−/− mice was associated with lower cytokine production and anticollagen antibody responses than in controls, indicating that p38γ and p38δ are crucial regulators of inflammatory joint destruction in CIA. Our findings indicate that p38γ and p38δ are potential therapeutic targets in complex diseases, such as rheumatoid arthritis, that involve innate and adaptive immune responses. |
---|---|
AbstractList | Objective
The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38γ and p38δ deficiency in the collagen‐induced arthritis (CIA) model.
Methods
Wild‐type, p38γ−/−, p38δ−/−, and p38γ/δ−/− mice were immunized with chicken type II collagen, and disease activity was evaluated by semiquantitative scoring and histologic assessment. Serum cytokine levels and in vitro T cell cytokine responses were quantified by flow cytometry and multiplex analysis, and serum anticollagen antibody levels by enzyme‐linked immunosorbent assay. Cytokine and p38 MAPK isoform expression in joints were determined by quantitative polymerase chain reaction.
Results
Compound p38γ and p38δ deficiency markedly reduced arthritis severity compared with that in wild‐type mice, whereas lack of either p38γ or p38δ had an intermediate effect. Joint damage was minimal in arthritic p38γ/δ−/− mice compared with wild‐type mice. The p38γ/δ−/− mice had lower levels of pathogenic anticollagen antibodies and interleukin‐1β (IL‐1β) and tumor necrosis factor α than controls. In vitro T cell assays showed reduced proliferation, interferon‐γ (IFNγ) production, and IL‐17 production by lymph node cells from p38γ/δ−/− mice. IL‐17 and IFNγ messenger RNA expression in joints was significantly inhibited in p38γ/δ−/− mice. Wild‐type chimeric mice with p38γ/δ−/− bone marrow did not show decreased CIA.
Conclusion
Reduced disease severity in p38γ/δ−/− mice was associated with lower cytokine production and anticollagen antibody responses than in controls, indicating that p38γ and p38δ are crucial regulators of inflammatory joint destruction in CIA. Our findings indicate that p38γ and p38δ are potential therapeutic targets in complex diseases, such as rheumatoid arthritis, that involve innate and adaptive immune responses. Objective The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38[gamma] and p38[delta] deficiency in the collagen-induced arthritis (CIA) model. Methods Wild-type, p38[gamma]-/-, p38[delta]-/-, and p38[gamma]/[delta]-/- mice were immunized with chicken type II collagen, and disease activity was evaluated by semiquantitative scoring and histologic assessment. Serum cytokine levels and in vitro T cell cytokine responses were quantified by flow cytometry and multiplex analysis, and serum anticollagen antibody levels by enzyme-linked immunosorbent assay. Cytokine and p38 MAPK isoform expression in joints were determined by quantitative polymerase chain reaction. Results Compound p38[gamma] and p38[delta] deficiency markedly reduced arthritis severity compared with that in wild-type mice, whereas lack of either p38[gamma] or p38[delta] had an intermediate effect. Joint damage was minimal in arthritic p38[gamma]/[delta]-/- mice compared with wild-type mice. The p38[gamma]/[delta]-/- mice had lower levels of pathogenic anticollagen antibodies and interleukin-1[beta] (IL-1[beta]) and tumor necrosis factor [alpha] than controls. In vitro T cell assays showed reduced proliferation, interferon-[gamma] (IFN[gamma]) production, and IL-17 production by lymph node cells from p38[gamma]/[delta]-/- mice. IL-17 and IFN[gamma] messenger RNA expression in joints was significantly inhibited in p38[gamma]/[delta]-/- mice. Wild-type chimeric mice with p38[gamma]/[delta]-/- bone marrow did not show decreased CIA. Conclusion Reduced disease severity in p38[gamma]/[delta]-/- mice was associated with lower cytokine production and anticollagen antibody responses than in controls, indicating that p38[gamma] and p38[delta] are crucial regulators of inflammatory joint destruction in CIA. Our findings indicate that p38[gamma] and p38[delta] are potential therapeutic targets in complex diseases, such as rheumatoid arthritis, that involve innate and adaptive immune responses. The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38γ and p38δ deficiency in the collagen-induced arthritis (CIA) model.OBJECTIVEThe role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38γ and p38δ deficiency in the collagen-induced arthritis (CIA) model.Wild-type, p38γ(-/-) , p38δ(-/-) , and p38γ/δ(-/-) mice were immunized with chicken type II collagen, and disease activity was evaluated by semiquantitative scoring and histologic assessment. Serum cytokine levels and in vitro T cell cytokine responses were quantified by flow cytometry and multiplex analysis, and serum anticollagen antibody levels by enzyme-linked immunosorbent assay. Cytokine and p38 MAPK isoform expression in joints were determined by quantitative polymerase chain reaction.METHODSWild-type, p38γ(-/-) , p38δ(-/-) , and p38γ/δ(-/-) mice were immunized with chicken type II collagen, and disease activity was evaluated by semiquantitative scoring and histologic assessment. Serum cytokine levels and in vitro T cell cytokine responses were quantified by flow cytometry and multiplex analysis, and serum anticollagen antibody levels by enzyme-linked immunosorbent assay. Cytokine and p38 MAPK isoform expression in joints were determined by quantitative polymerase chain reaction.Compound p38γ and p38δ deficiency markedly reduced arthritis severity compared with that in wild-type mice, whereas lack of either p38γ or p38δ had an intermediate effect. Joint damage was minimal in arthritic p38γ/δ(-/-) mice compared with wild-type mice. The p38γ/δ(-/-) mice had lower levels of pathogenic anticollagen antibodies and interleukin-1β (IL-1β) and tumor necrosis factor α than controls. In vitro T cell assays showed reduced proliferation, interferon-γ (IFNγ) production, and IL-17 production by lymph node cells from p38γ/δ(-/-) mice. IL-17 and IFNγ messenger RNA expression in joints was significantly inhibited in p38γ/δ(-/-) mice. Wild-type chimeric mice with p38γ/δ(-/-) bone marrow did not show decreased CIA.RESULTSCompound p38γ and p38δ deficiency markedly reduced arthritis severity compared with that in wild-type mice, whereas lack of either p38γ or p38δ had an intermediate effect. Joint damage was minimal in arthritic p38γ/δ(-/-) mice compared with wild-type mice. The p38γ/δ(-/-) mice had lower levels of pathogenic anticollagen antibodies and interleukin-1β (IL-1β) and tumor necrosis factor α than controls. In vitro T cell assays showed reduced proliferation, interferon-γ (IFNγ) production, and IL-17 production by lymph node cells from p38γ/δ(-/-) mice. IL-17 and IFNγ messenger RNA expression in joints was significantly inhibited in p38γ/δ(-/-) mice. Wild-type chimeric mice with p38γ/δ(-/-) bone marrow did not show decreased CIA.Reduced disease severity in p38γ/δ(-/-) mice was associated with lower cytokine production and anticollagen antibody responses than in controls, indicating that p38γ and p38δ are crucial regulators of inflammatory joint destruction in CIA. Our findings indicate that p38γ and p38δ are potential therapeutic targets in complex diseases, such as rheumatoid arthritis, that involve innate and adaptive immune responses.CONCLUSIONReduced disease severity in p38γ/δ(-/-) mice was associated with lower cytokine production and anticollagen antibody responses than in controls, indicating that p38γ and p38δ are crucial regulators of inflammatory joint destruction in CIA. Our findings indicate that p38γ and p38δ are potential therapeutic targets in complex diseases, such as rheumatoid arthritis, that involve innate and adaptive immune responses. The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38γ and p38δ deficiency in the collagen-induced arthritis (CIA) model. Wild-type, p38γ(-/-) , p38δ(-/-) , and p38γ/δ(-/-) mice were immunized with chicken type II collagen, and disease activity was evaluated by semiquantitative scoring and histologic assessment. Serum cytokine levels and in vitro T cell cytokine responses were quantified by flow cytometry and multiplex analysis, and serum anticollagen antibody levels by enzyme-linked immunosorbent assay. Cytokine and p38 MAPK isoform expression in joints were determined by quantitative polymerase chain reaction. Compound p38γ and p38δ deficiency markedly reduced arthritis severity compared with that in wild-type mice, whereas lack of either p38γ or p38δ had an intermediate effect. Joint damage was minimal in arthritic p38γ/δ(-/-) mice compared with wild-type mice. The p38γ/δ(-/-) mice had lower levels of pathogenic anticollagen antibodies and interleukin-1β (IL-1β) and tumor necrosis factor α than controls. In vitro T cell assays showed reduced proliferation, interferon-γ (IFNγ) production, and IL-17 production by lymph node cells from p38γ/δ(-/-) mice. IL-17 and IFNγ messenger RNA expression in joints was significantly inhibited in p38γ/δ(-/-) mice. Wild-type chimeric mice with p38γ/δ(-/-) bone marrow did not show decreased CIA. Reduced disease severity in p38γ/δ(-/-) mice was associated with lower cytokine production and anticollagen antibody responses than in controls, indicating that p38γ and p38δ are crucial regulators of inflammatory joint destruction in CIA. Our findings indicate that p38γ and p38δ are potential therapeutic targets in complex diseases, such as rheumatoid arthritis, that involve innate and adaptive immune responses. |
Author | Pérez‐Lorenzo, María J. Risco, Ana Alsina‐Beauchamp, Dayanira Cuenda, Ana Escós, Alejandra Criado, Gabriel |
Author_xml | – sequence: 1 givenname: Gabriel surname: Criado fullname: Criado, Gabriel organization: Instituto de Investigación Sanitaria and Hospital Universitario 12 de Octubre – sequence: 2 givenname: Ana surname: Risco fullname: Risco, Ana organization: Centro Nacional de Biotecnología, CSIC – sequence: 3 givenname: Dayanira surname: Alsina‐Beauchamp fullname: Alsina‐Beauchamp, Dayanira organization: Centro Nacional de Biotecnología, CSIC – sequence: 4 givenname: María J. surname: Pérez‐Lorenzo fullname: Pérez‐Lorenzo, María J. organization: Instituto de Investigación Sanitaria and Hospital Universitario 12 de Octubre – sequence: 5 givenname: Alejandra surname: Escós fullname: Escós, Alejandra organization: Centro Nacional de Biotecnología, CSIC – sequence: 6 givenname: Ana surname: Cuenda fullname: Cuenda, Ana organization: Centro Nacional de Biotecnología, CSIC |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24782184$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc1OAjEUhRujEUQWvoCZxI0uBvrLzCwniErEaAyum1IuWjLMYNvRsPMRfEafxCqwIdpNu_jO6T33HKH9sioBoROCOwRj2lXWd1jKaLKHmpTRXiwoFvvbN8lIA7Wdm-NwsgT3sDhEDcqTlJKUN9FlXniwpfLmDaIlS6O7_OHWRbmFaOAclN6oIppVNupXRaGeofz6-ByW01rDNED-xRpv3DE6mKnCQXtzt9DT1WDcv4lH99fDfj6KNSdZEoPQGPiM6Mkkwz0tmEoEI4JCClglRFFBOQiumNBZKtI00SEf4WqqWcg00ayFzte-S1u91uC8XBinIQxWQlU7Gbww44IlLKBnO-i8qkPOIlDhV5phnvFAnW6oerKAqVxas1B2Jbf7CUB3DWhbOWdhJrXxYVlV6a0yhSRY_pQgQwnyt4SguNhRbE3_Yjfu76aA1f-gzB_Ha8U3HfqTIw |
CitedBy_id | crossref_primary_10_18632_oncotarget_6535 crossref_primary_10_3389_fmed_2022_849990 crossref_primary_10_3390_cells12131674 crossref_primary_10_1016_j_freeradbiomed_2016_06_001 crossref_primary_10_1007_s11010_017_3212_9 crossref_primary_10_3389_fcell_2016_00031 crossref_primary_10_3389_fimmu_2022_960544 crossref_primary_10_1007_s00281_014_0442_8 crossref_primary_10_1007_s10528_020_10016_9 crossref_primary_10_1016_j_intimp_2020_106823 crossref_primary_10_1155_2014_272689 crossref_primary_10_3389_fcell_2020_00189 crossref_primary_10_1016_j_intimp_2016_09_006 crossref_primary_10_1016_j_tibs_2017_02_008 crossref_primary_10_1093_brain_awad421 crossref_primary_10_1128_JVI_01100_19 crossref_primary_10_1016_j_fct_2015_08_017 crossref_primary_10_1186_s12974_016_0556_0 crossref_primary_10_18632_oncotarget_4320 crossref_primary_10_1002_mnfr_201500304 crossref_primary_10_3389_fcell_2023_1083033 crossref_primary_10_3389_fcell_2016_00067 crossref_primary_10_1038_s41573_020_0082_8 crossref_primary_10_1007_s00394_015_0850_0 crossref_primary_10_1158_0008_5472_CAN_14_0870 crossref_primary_10_1016_j_fct_2019_01_005 crossref_primary_10_1016_j_bbagen_2016_06_023 crossref_primary_10_3389_fimmu_2018_00065 crossref_primary_10_1016_j_ejphar_2014_08_031 crossref_primary_10_15252_embj_201591857 crossref_primary_10_1136_rmdopen_2015_000093 crossref_primary_10_1038_srep29881 crossref_primary_10_15252_emmm_201708485 crossref_primary_10_3390_cancers13092077 crossref_primary_10_1107_S1399004715001212 crossref_primary_10_3389_fphar_2018_00105 crossref_primary_10_3892_mmr_2015_3759 |
Cites_doi | 10.1073/pnas.1207290109 10.1172/JCI36389 10.1186/ar2319 10.1002/art.11227 10.1038/sj.emboj.7600578 10.2174/1568026611313060003 10.1111/j.1600-065X.2008.00744.x 10.1016/j.ejphar.2004.11.013 10.1128/MCB.25.23.10454-10464.2005 10.1016/j.bbamcr.2007.03.010 10.1093/emboj/16.2.295 10.1007/BF02684010 10.1073/pnas.180316397 10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R 10.1002/art.34477 10.1124/jpet.108.139006 10.1002/art.22080 10.1002/art.34489 10.2174/1874312901206010209 10.1074/jbc.M414221200 10.1084/jem.154.3.688 10.1016/j.cellsig.2009.11.020 10.1084/jem.20120677 10.1002/art.21626 10.1084/jem.20070906 10.1002/art.24264 10.1042/BJ20070797 10.1016/j.clim.2009.03.522 10.4049/jimmunol.0901026 10.1073/pnas.0509188103 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K 10.1038/nature01661 10.1016/j.molmed.2009.06.005 10.1073/pnas.1009234107 10.1016/j.ceb.2009.01.015 10.1016/S1097-2765(05)00014-6 10.1002/art.33359 10.1186/ar294 10.1084/jem.191.5.859 10.1002/art.34391 10.4049/jimmunol.0900483 10.1016/S0092-8674(00)00027-1 10.1038/nrd2829 10.4049/jimmunol.177.3.1913 |
ContentType | Journal Article |
Copyright | Copyright © 2014 by the American College of Rheumatology Copyright © 2014 by the American College of Rheumatology. |
Copyright_xml | – notice: Copyright © 2014 by the American College of Rheumatology – notice: Copyright © 2014 by the American College of Rheumatology. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7QP 7T5 7TM 7U7 C1K H94 K9. 7X8 |
DOI | 10.1002/art.38327 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Immunology Abstracts Nucleic Acids Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Toxicology Abstracts Bacteriology Abstracts (Microbiology B) Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Calcium & Calcified Tissue Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Toxicology Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2326-5205 |
EndPage | 1217 |
ExternalDocumentID | 3911919081 24782184 10_1002_art_38327 ART38327 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: MINECO FPI Fellowship – fundername: Instituto de Salud Carlos III RETICS Programme funderid: RD08/0075 RIER – fundername: MINECO Miguel Servet Fellowship – fundername: Spanish Ministry of Economy and Competitiveness funderid: MINECO; CP07/250; BFU2010‐19734 |
GroupedDBID | 0R~ 1OC 24P 33P 3SF 4.4 52O 52U 52V 53G 5VS AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAQQT AASGY AAWTL AAXRX AAYCA AAZKR ABCUV ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZFZN AZVAB BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 DCZOG DIK DRFUL DRMAN DRSTM EBS EJD EMOBN EX3 F00 FUBAC G-S G.N GODZA HGLYW KBYEO LATKE LEEKS LH4 LITHE LOXES LUTES LW6 LYRES MEWTI MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM NF~ O66 O9- OK1 OVD P2W PQQKQ QB0 ROL SUPJJ SV3 TEORI V9Y WBKPD WHWMO WIH WIJ WIK WOHZO WVDHM WXSBR YCJ AAFWJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7QL 7QP 7T5 7TM 7U7 AAMMB AEFGJ AGXDD AIDQK AIDYY C1K H94 K9. 7X8 |
ID | FETCH-LOGICAL-c4197-e5c0e4f1cbb906c53a753152e8e0a71a2524e54a35c985887c00214adc3520bc3 |
ISSN | 2326-5191 2326-5205 |
IngestDate | Fri Jul 11 07:16:43 EDT 2025 Fri Jul 25 12:07:13 EDT 2025 Wed Feb 19 01:56:56 EST 2025 Tue Jul 01 00:33:09 EDT 2025 Thu Apr 24 23:05:22 EDT 2025 Wed Jan 22 16:21:14 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor Copyright © 2014 by the American College of Rheumatology. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4197-e5c0e4f1cbb906c53a753152e8e0a71a2524e54a35c985887c00214adc3520bc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 24782184 |
PQID | 1753290494 |
PQPubID | 946334 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1520345373 proquest_journals_1753290494 pubmed_primary_24782184 crossref_citationtrail_10_1002_art_38327 crossref_primary_10_1002_art_38327 wiley_primary_10_1002_art_38327_ART38327 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | May 2014 |
PublicationDateYYYYMMDD | 2014-05-01 |
PublicationDate_xml | – month: 05 year: 2014 text: May 2014 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Atlanta |
PublicationTitle | Arthritis & rheumatology (Hoboken, N.J.) |
PublicationTitleAlternate | Arthritis Rheumatol |
PublicationYear | 2014 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2009; 21 2000; 6 2010; 107 2006; 54 2009; 60 2002; 51 2000; 43 2009; 132 2008; 327 2008; 205 2007; 408 2006; 177 2012; 109 2005; 24 2000; 191 2012; 209 2005; 25 2010; 22 2005; 280 2007; 1773 2000; 102 2013; 13 2000; 30 1981; 154 2000; 97 2007; 9 2008; 118 2003; 48 2009; 8 2005; 506 1997; 16 2009; 183 2001; 3 2003; 423 2009; 228 2012; 6 2009; 15 2012; 64 2006; 103 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_14_1 e_1_2_7_42_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_37_1 e_1_2_7_38_1 e_1_2_7_39_1 |
References_xml | – volume: 25 start-page: 10454 year: 2005 end-page: 64 article-title: Generation and characterization of p38β (MAPK11) gene‐targeted mice publication-title: Mol Cell Biol – volume: 13 start-page: 705 year: 2013 end-page: 11 article-title: Immunopathology of rheumatoid arthritis publication-title: Curr Top Med Chem – volume: 107 start-page: 14292 year: 2010 end-page: 7 article-title: Proinflammatory T helper type 17 cells are effective B‐cell helpers publication-title: Proc Natl Acad Sci U S A – volume: 8 start-page: 480 year: 2009 end-page: 99 article-title: Targeting innate immunity protein kinase signalling in inflammation publication-title: Nat Rev Drug Discov – volume: 64 start-page: 2147 year: 2012 end-page: 57 article-title: Bone marrow–derived and synovium‐derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: contribution to the chronicity of rheumatoid arthritis publication-title: Arthritis Rheum – volume: 24 start-page: 1134 year: 2005 end-page: 45 article-title: p38γ regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP publication-title: EMBO J – volume: 60 start-page: 317 year: 2009 end-page: 20 article-title: Inhibition of p38: has the fat lady sung? publication-title: Arthritis Rheum – volume: 3 start-page: 168 year: 2001 end-page: 77 article-title: IL‐17 derived from juxta‐articular bone and synovium contributes to joint degradation in rheumatoid arthritis publication-title: Arthritis Res – volume: 51 start-page: 102 year: 2002 end-page: 4 article-title: Overexpression of IL‐17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction publication-title: Inflamm Res – volume: 132 start-page: 295 year: 2009 end-page: 304 article-title: Breaking old paradigms: Th17 cells in autoimmune arthritis publication-title: Clin Immunol – volume: 54 start-page: 2745 year: 2006 end-page: 56 article-title: Differential tissue expression and activation of p38 MAPK α, β, γ, and δ isoforms in rheumatoid arthritis publication-title: Arthritis Rheum – volume: 64 start-page: 678 year: 2012 end-page: 87 article-title: Decreased collagen‐induced arthritis severity and adaptive immunity in MKK‐6–deficient mice publication-title: Arthritis Rheum – volume: 54 start-page: 463 year: 2006 end-page: 72 article-title: Activation of p38 MAPK is a key step in tumor necrosis factor–mediated inflammatory bone destruction publication-title: Arthritis Rheum – volume: 9 start-page: R113 year: 2007 article-title: Collagen‐induced arthritis in C57BL/6 mice is associated with a robust and sustained T‐cell response to type II collagen publication-title: Arthritis Res Ther – volume: 183 start-page: 5938 year: 2009 end-page: 47 article-title: The α‐isoform of p38 MAPK specifically regulates arthritic bone loss publication-title: J Immunol – volume: 6 start-page: 109 year: 2000 end-page: 16 article-title: Essential role of p38α MAP kinase in placental but not embryonic cardiovascular development publication-title: Mol Cell – volume: 506 start-page: 285 year: 2005 end-page: 95 article-title: R‐130823, a novel inhibitor of p38 MAPK, ameliorates hyperalgesia and swelling in arthritis models publication-title: Eur J Pharmacol – volume: 154 start-page: 688 year: 1981 end-page: 700 article-title: Type II collagen‐induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates publication-title: J Exp Med – volume: 327 start-page: 610 year: 2008 end-page: 9 article-title: Pamapimod, a novel p38 mitogen‐activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity publication-title: J Pharmacol Exp Ther – volume: 103 start-page: 5484 year: 2006 end-page: 9 article-title: Mitogen‐activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis publication-title: Proc Natl Acad Sci U S A – volume: 15 start-page: 369 year: 2009 end-page: 79 article-title: p38(MAPK): stress responses from molecular mechanisms to therapeutics publication-title: Trends Mol Med – volume: 228 start-page: 212 year: 2009 end-page: 24 article-title: Regulation of the immune response by stress‐activated protein kinases publication-title: Immunol Rev – volume: 64 start-page: 2499 year: 2012 end-page: 503 article-title: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis publication-title: Arthritis Rheum – volume: 1773 start-page: 1358 year: 2007 end-page: 75 article-title: p38 MAP‐kinases pathway regulation, function and role in human diseases publication-title: Biochim Biophys Acta – volume: 183 start-page: 1360 year: 2009 end-page: 7 article-title: Role of MAPK kinase 6 in arthritis: distinct mechanism of action in inflammation and cytokine expression publication-title: J Immunol – volume: 64 start-page: 2887 year: 2012 end-page: 95 article-title: Antiinflammatory functions of p38 in mouse models of rheumatoid arthritis: advantages of targeting upstream kinases MKK‐3 or MKK‐6 publication-title: Arthritis Rheum – volume: 209 start-page: 2229 year: 2012 end-page: 46 article-title: Regulation of PTEN activity by p38δ‐PKD1 signaling in neutrophils confers inflammatory responses in the lung publication-title: J Exp Med – volume: 205 start-page: 331 year: 2008 end-page: 7 article-title: Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases publication-title: J Exp Med – volume: 22 start-page: 660 year: 2010 end-page: 7 article-title: Differential activation of p38MAPK isoforms by MKK6 and MKK3 publication-title: Cell Signal – volume: 109 start-page: 11200 year: 2012 end-page: 5 article-title: p38γ and p38δ kinases regulate the Toll‐like receptor 4 (TLR4)‐induced cytokine production by controlling ERK1/2 protein kinase pathway activation publication-title: Proc Natl Acad Sci U S A – volume: 191 start-page: 859 year: 2000 end-page: 70 article-title: Deficiency of the stress kinase p38α results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme‐deficient embryonic stem cells publication-title: J Exp Med – volume: 97 start-page: 10454 year: 2000 end-page: 9 article-title: Essential role for p38α mitogen‐activated protein kinase in placental angiogenesis publication-title: Proc Natl Acad Sci U S A – volume: 280 start-page: 19472 year: 2005 end-page: 9 article-title: BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo publication-title: J Biol Chem – volume: 30 start-page: 1568 year: 2000 end-page: 75 article-title: Collagen‐induced arthritis in C57BL/6 (H‐2 ) mice: new insights into an important disease model of rheumatoid arthritis publication-title: Eur J Immunol – volume: 408 start-page: 297 year: 2007 end-page: 315 article-title: The selectivity of protein kinase inhibitors: a further update publication-title: Biochem J – volume: 6 start-page: 209 year: 2012 end-page: 19 article-title: The p38 MAPK pathway in rheumatoid arthritis: a sideways look publication-title: Open Rheumatol J – volume: 16 start-page: 295 year: 1997 end-page: 305 article-title: Activation of stress‐activated protein kinase‐3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6): comparison of the specificities of SAPK3 and SAPK2 (RK/p38) publication-title: EMBO J – volume: 43 start-page: 2501 year: 2000 end-page: 12 article-title: Activation, differential localization, and regulation of the stress‐activated protein kinases, extracellular signal– regulated kinase, c‐JUN N‐terminal kinase, and p38 mitogen‐activated protein kinase, in synovial tissue and cells in rheumatoid arthritis publication-title: Arthritis Rheum – volume: 118 start-page: 3537 year: 2008 end-page: 45 article-title: Evidence that cytokines play a role in rheumatoid arthritis publication-title: J Clin Invest – volume: 21 start-page: 317 year: 2009 end-page: 24 article-title: Targeting protein kinases for the development of anti‐inflammatory drugs publication-title: Curr Opin Cell Biol – volume: 48 start-page: 2670 year: 2003 end-page: 81 article-title: Prevention of the onset and progression of collagen‐induced arthritis in rats by the potent p38 mitogen‐activated protein kinase inhibitor FR167653 publication-title: Arthritis Rheum – volume: 423 start-page: 356 year: 2003 end-page: 61 article-title: Evolving concepts of rheumatoid arthritis publication-title: Nature – volume: 177 start-page: 1913 year: 2006 end-page: 7 article-title: MAPKAP kinase 2‐deficient mice are resistant to collagen‐induced arthritis publication-title: J Immunol – volume: 102 start-page: 221 year: 2000 end-page: 31 article-title: Requirement for p38α in erythropoietin expression: a role for stress kinases in erythropoiesis publication-title: Cell – ident: e_1_2_7_23_1 doi: 10.1073/pnas.1207290109 – ident: e_1_2_7_3_1 doi: 10.1172/JCI36389 – ident: e_1_2_7_26_1 doi: 10.1186/ar2319 – ident: e_1_2_7_10_1 doi: 10.1002/art.11227 – ident: e_1_2_7_24_1 doi: 10.1038/sj.emboj.7600578 – ident: e_1_2_7_44_1 doi: 10.2174/1568026611313060003 – ident: e_1_2_7_8_1 doi: 10.1111/j.1600-065X.2008.00744.x – ident: e_1_2_7_11_1 doi: 10.1016/j.ejphar.2004.11.013 – ident: e_1_2_7_29_1 doi: 10.1128/MCB.25.23.10454-10464.2005 – ident: e_1_2_7_5_1 doi: 10.1016/j.bbamcr.2007.03.010 – ident: e_1_2_7_25_1 doi: 10.1093/emboj/16.2.295 – ident: e_1_2_7_38_1 doi: 10.1007/BF02684010 – ident: e_1_2_7_31_1 doi: 10.1073/pnas.180316397 – ident: e_1_2_7_27_1 doi: 10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R – ident: e_1_2_7_35_1 doi: 10.1002/art.34477 – ident: e_1_2_7_12_1 doi: 10.1124/jpet.108.139006 – ident: e_1_2_7_21_1 doi: 10.1002/art.22080 – ident: e_1_2_7_34_1 doi: 10.1002/art.34489 – ident: e_1_2_7_45_1 doi: 10.2174/1874312901206010209 – ident: e_1_2_7_15_1 doi: 10.1074/jbc.M414221200 – ident: e_1_2_7_28_1 doi: 10.1084/jem.154.3.688 – ident: e_1_2_7_7_1 doi: 10.1016/j.cellsig.2009.11.020 – ident: e_1_2_7_22_1 doi: 10.1084/jem.20120677 – ident: e_1_2_7_41_1 doi: 10.1002/art.21626 – ident: e_1_2_7_43_1 doi: 10.1084/jem.20070906 – ident: e_1_2_7_13_1 doi: 10.1002/art.24264 – ident: e_1_2_7_14_1 doi: 10.1042/BJ20070797 – ident: e_1_2_7_37_1 doi: 10.1016/j.clim.2009.03.522 – ident: e_1_2_7_20_1 doi: 10.4049/jimmunol.0901026 – ident: e_1_2_7_18_1 doi: 10.1073/pnas.0509188103 – ident: e_1_2_7_40_1 doi: 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K – ident: e_1_2_7_2_1 doi: 10.1038/nature01661 – ident: e_1_2_7_9_1 doi: 10.1016/j.molmed.2009.06.005 – ident: e_1_2_7_39_1 doi: 10.1073/pnas.1009234107 – ident: e_1_2_7_4_1 doi: 10.1016/j.ceb.2009.01.015 – ident: e_1_2_7_30_1 doi: 10.1016/S1097-2765(05)00014-6 – ident: e_1_2_7_17_1 doi: 10.1002/art.33359 – ident: e_1_2_7_36_1 doi: 10.1186/ar294 – ident: e_1_2_7_33_1 doi: 10.1084/jem.191.5.859 – ident: e_1_2_7_42_1 doi: 10.1002/art.34391 – ident: e_1_2_7_16_1 doi: 10.4049/jimmunol.0900483 – ident: e_1_2_7_32_1 doi: 10.1016/S0092-8674(00)00027-1 – ident: e_1_2_7_6_1 doi: 10.1038/nrd2829 – ident: e_1_2_7_19_1 doi: 10.4049/jimmunol.177.3.1913 |
SSID | ssj0000970605 |
Score | 2.3083973 |
Snippet | Objective
The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38γ and p38δ deficiency in the... The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38γ and p38δ deficiency in the... Objective The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38[gamma] and p38[delta] deficiency... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1208 |
SubjectTerms | Animals Arthritis Arthritis, Experimental - metabolism Collagen Cytokines Disease Models, Animal Disease Progression Female Interferon-gamma - metabolism Interleukin-17 - metabolism Interleukin-1beta - metabolism Male Mice Mice, Inbred C57BL Mice, Knockout Mitogen-Activated Protein Kinase 12 - deficiency Mitogen-Activated Protein Kinase 12 - genetics Mitogen-Activated Protein Kinase 12 - metabolism Mitogen-Activated Protein Kinase 13 - deficiency Mitogen-Activated Protein Kinase 13 - genetics Mitogen-Activated Protein Kinase 13 - metabolism Rodents Tumor Necrosis Factor-alpha - metabolism |
Title | Alternative p38 MAPKs Are Essential for Collagen‐Induced Arthritis |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fart.38327 https://www.ncbi.nlm.nih.gov/pubmed/24782184 https://www.proquest.com/docview/1753290494 https://www.proquest.com/docview/1520345373 |
Volume | 66 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLbKkBA3iP8VBgqIi0lVSuLYqXMZtkHpKJrQJu0uclxPrShJlTRI9IpH4F14I56E4596KR3S4CaKHDt2co7t79jnfEboVRxNwK4S3Fdk4GCgiNhnPBA-x7GADsIirr0Jxx_j4RkZndPzTudny2upWeZ9sboyruR_pAppIFcVJfsPknUvhQS4B_nCFSQM12vJOJ3b5byvsreIWG-cnhzXvbSSvaNaBRXNTHSiXh2AcaNwng3qwA618Z9Wy6lmNWpjVJeo1aKaygZQraFqAjg6LPPys7RRWqN-ayXhAL54olde3_EcLHDnu_FpVgsTTVO4SSCd17OCuwa9kbwRU_5lYfzsv_FiVrm8J2Y3v5Irl_9DWcliVdpoI_38kPdG_fYiRkguXQbNWAe4LvYBTJok2UrDAW0P1uaIFquUtDXyhjhgrVk8xCYkdGuGMIyzILI-2OaGlmCThfuP2dH5LBp-Z5xB0UwXvYFu4gEANoXE3x-7hb0gUYREVB9qaD9qzWgV4Neu4k0ctGXcbNpKGuyc3kV3rJXipUbl7qGOLO6jW2Prh_EAHbY0zwPN87TmQX7pOc3zQPO8teb9-v7D6pzn1OshOnt7dHow9O15HL4gYTLwJRWBJBehyPMkiAWNONi6gP8kkwEfhBxTTCQlPKIiYRRmL6EZ-fhEAMoPchE9QjtFWchd5F3wOIcpPyECUyInLIEiAC1pTAQTWLAu2l__nUxYsnp1Zso82xJDF710WReGoeWqTHvrX5zZDlxniqQWJ4ogqYteuMcwvKo9M17IsoE80PKI0GgQddFjIxpXCyYAr0MGpfe1rP5efQbGqb55cp3GPkW3L_vIHtpZVo18BtB3mT_XqvYbioekHA |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alternative+p38+MAPKs+Are+Essential+for+Collagen%E2%80%90Induced+Arthritis&rft.jtitle=Arthritis+%26+rheumatology+%28Hoboken%2C+N.J.%29&rft.au=Criado%2C+Gabriel&rft.au=Risco%2C+Ana&rft.au=Alsina%E2%80%90Beauchamp%2C+Dayanira&rft.au=P%C3%A9rez%E2%80%90Lorenzo%2C+Mar%C3%ADa+J.&rft.date=2014-05-01&rft.issn=2326-5191&rft.eissn=2326-5205&rft.volume=66&rft.issue=5&rft.spage=1208&rft.epage=1217&rft_id=info:doi/10.1002%2Fart.38327&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_art_38327 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2326-5191&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2326-5191&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2326-5191&client=summon |